Results 221 to 230 of about 58,995 (250)

Contrast-Induced Nephropathy (CIN) After Invasive Treatment of Acute Coronary Syndromes-Predictors, Short and Long-Term Outcome. [PDF]

J Clin Med
Sielski J, Kaziród-Wolski K, Piotrowska AM, Jurczak B, Klasa A, Kozieł K, Ludew M, Maj F, Merchel L, Pytlak K, Zabojszcz M, Siudak Z.   +11 more
europepmc   +1 more source

Joint modeling of longitudinal and time‐to‐event data for dynamic disease risk prediction using proteomics

Protein Science, Volume 35, Issue 6, June 2026.
Abstract Biomedical studies increasingly incorporate longitudinal data, enabling us to track individual disease processes over time at the molecular level, and to discover associations of the molecular profiles with the outcome of interest, such as the onset of a disease.
Markus Lindén, Tea Ammunét, Tommi Välikangas, Laura L. Elo, Tomi Suomi   +4 more
wiley   +1 more source

The role of carbon dioxide angiography in reducing contrast-induced nephropathy in diabetic foot patients undergoing endovascular treatment. [PDF]

Turk J Med Sci
Uyanik SA, Birgi E, Öztürk S, Asfuroğlu U, Tangobay E, Güven HE.   +5 more
europepmc   +1 more source

Biomarkers in Contrast-Induced Nephropathy: Advances in Early Detection, Risk Assessment, and Prevention Strategies. [PDF]

Int J Mol Sci
Lee PH, Huang SM, Tsai YC, Wang YT, Chew FY.   +4 more
europepmc   +1 more source

Experimental study of intravoxel incoherent motion diffusion imaging combined with ultrasound renal resistance index in contrast-induced nephropathy. [PDF]

BMC Nephrol
Chen J, Song X, Wang Z, Wang Z.
europepmc   +1 more source

Erratum to " The role of carbon dioxide angiography in reducing contrast-induced nephropathy in diabetic foot patients undergoing endovascular treatment" [Turkish Journal of Medical Sciences 55 (4): 877-886]. [PDF]

Turk J Med Sci
Uyanik SA, Birgi E, Öztürk S, Asfuroğlu U, Tangobay E, Güven HE.   +5 more
europepmc   +1 more source

Incidence and risk factors for contrast-induced nephropathy after angioplasty: an observational retrospective study. [PDF]

J Vasc Bras
Peres J, Toregeani JF, Pohl AC, Vendrametto AJ, de Andrade L, Moro AB.   +5 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Combination of atorvastatin plus N-acetylcysteine versus atorvastatin alone to prevent contrast-induced nephropathy. [PDF]

Arch Med Sci Atheroscler Dis
Habib M.
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source